Home › Dermatomyositis › North Carolina › Durham
Dermatomyositis clinical trials in Durham, NC
8 studies for Dermatomyositis are looking for participants at sites in and around Durham (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy
RecruitingPhase 2/3
- Duke University Medical Center - Accepting Young Adults and Juvenile Patients, Durham
- University of North Carolina at Chapel Hill - Accepting Adult Patients, Chapel Hill · 10 mi away
A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
RecruitingPhase 1
- Duke University Medical Center, Durham
A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants With Systemic Lupus Erythematosus or Idiopathic Inflammatory Myopathies or Rheumatoid Arthritis.
RecruitingPhase 1
- Research Site, Chapel Hill · 10 mi away
Environmental Risk Factors for the Anti-synthetase Syndrome
RecruitingObservational studyHealthy volunteers welcome
- NIEHS Clinical Research Unit (CRU), Research Triangle Park · 7 mi away
A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared With Placebo Added to Standard of Care in Adult Participants With Idiopathic Inflammatory Myopathies (Polymyositis and Dermatomyositis)
RecruitingPhase 3
- Research Site, Durham
Adult and Juvenile Myositis
RecruitingObservational studyHealthy volunteers welcome
- NIEHS Clinical Research Unit (CRU), Research Triangle Park · 7 mi away
Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)
RecruitingPhase 1
- Universtity of North Carolina at Chapel Hill, Chapel Hill · 10 mi away
A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases
RecruitingPhase 1
- Duke University, Durham
Dermatomyositis trials in other cities
- Washington, DC7 studies
- Boston, MA5 studies
- Pittsburgh, PA5 studies
- Houston, TX5 studies
- New York City, NY5 studies
- Miami, FL4 studies
- Philadelphia, PA4 studies
- Baltimore, MD4 studies
- Phoenix, AZ3 studies
- Cleveland, OH3 studies
- Jacksonville, FL3 studies
- New Haven, CT3 studies
Other studies in Durham
- Breast Cancer63 studies
- Cancer (all types)61 studies
- Non-Small Cell Lung Cancer42 studies
- Multiple Myeloma36 studies
- Acute Myeloid Leukemia34 studies
- Lung Cancer33 studies
- Metastatic Cancer33 studies
- Prostate Cancer32 studies
- Colorectal Cancer30 studies
- Ovarian Cancer28 studies
- Chronic Lymphocytic Leukemia28 studies
- Heart Failure25 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.